Publications by authors named "Kirk Habegger"

Claim this Profile
I
IUPHAR review: From foe to friend: Repurposing glucagon to treat obesity and type 2 diabetes.
Andrew J Elmendorf, Mostafa Yousefian, Il-Man Kim, J Andrew Hardaway, Kirk Habegger

Pharmacol Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bile Acid Binding Resins Improve Glucagon Receptor Agonist-Mediated Weight Loss in Diet-Induced Obese Mice.
Teayoun Kim, Mackenzie J Pearson, Huixian Hong, Shelly Nason, Khadija Seck, Kirk Habegger

Obesity (Silver Spring)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: The impact of GIP/GIPR on metabolic diseases: how the field is evolving.
Kirk Habegger, Alejandra Tomas, Roger Chen, Charles Harris, William Roell

Front Endocrinol (Lausanne)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A consensus guide to preclinical indirect calorimetry experiments.
Alexander S Banks, David B Allison, Thierry Alquier, Ansarullah, Steven N Austad, Kirk M Habegger

Nat Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a targeted oral pharmacologic duodenal exclusion therapy for the treatment of metabolic diseases.
Taylor L Carlson, Kevin Colbert, Marcela Vieira, Florence V Guerina, Christine L N Bryant, Kirk Habegger

Sci Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of LY3324954 a long-acting glucagon-receptor agonist.
William Roell, Tamer Coskun, Teayoun Kim, Libbey O'Farrell, Jennifer A Martin, Kirk M Habegger

Mol Metab· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptin resistance in children with in utero exposure to maternal obesity and gestational diabetes.
Alysha B Everett, W Timothy Garvey, Jose R Fernandez, Kirk Habegger, Lorie M Harper

Pediatr Obes· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Roles for the Transcriptional Repressor E4BP4 in Both Cardiac Physiology and Pathophysiology.
Sobuj Mia, Ravi Sonkar, Lamario Williams, Mary N Latimer, David R Rawnsley, Kirk M Habegger

JACC Basic Transl Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An early, reversible cholesterolgenic etiology of diet-induced insulin resistance.
Jacob D Covert, Brian A Grice, Matthew G Thornburg, Manpreet Kaur, Andrew P Ryan, Kirk M Habegger

Mol Metab· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity and Overweight: Probing Causes, Consequences, and Novel Therapeutic Approaches Through the American Heart Association's Strategically Focused Research Network.
Jeanne M Clark, W Timothy Garvey, Kevin D Niswender, Ann Marie Schmidt, Rexford S Ahima, Kirk M Habegger

J Am Heart Assoc· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic mTORC2 Signaling Facilitates Acute Glucagon Receptor Enhancement of Insulin-Stimulated Glucose Homeostasis in Mice.
Teayoun Kim, Shelly Nason, Jessica Antipenko, Brian Finan, Anath Shalev, Kirk M Habegger

Diabetes· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mother-child cardiometabolic health 4-10 years after pregnancy complicated by obesity with and without gestational diabetes.
Samantha L Martin, Li Zhang, Makenzie L Callahan, Jessica Bahorski, Cora E Lewis, Kirk Habegger

Obes Sci Pract· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte.
Kirk M Habegger

Diabetes· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transcriptional co-regulator LDB1 is required for brown adipose function.
Jessica D Kepple, Yanping Liu, Teayoun Kim, Cheryl Cero, James W Johnson, Kirk M Habegger

Mol Metab· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mito-Mendelian interactions alter in vivo glucose metabolism and insulin sensitivity in healthy mice.
Melissa J Sammy, Ashley W Connelly, Jamelle A Brown, Cassie Holleman, Kirk M Habegger

Am J Physiol Endocrinol Metab· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ablation of Sam68 in adult mice increases thermogenesis and energy expenditure.
Aijun Qiao, Wenxia Ma, Jianxin Deng, Junlan Zhou, Chaoshan Han, Kirk M Habegger

FASEB J· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sam68 promotes hepatic gluconeogenesis via CRTC2.
Aijun Qiao, Junlan Zhou, Shiyue Xu, Wenxia Ma, Chan Boriboun, Kirk M Habegger

Nat Commun· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon's Metabolic Action in Health and Disease.
Anja Zeigerer, Revathi Sekar, Maximilian Kleinert, Shelly Nason, Kirk M Habegger

Compr Physiol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon receptor signaling regulates weight loss via central KLB receptor complexes.
Shelly R Nason, Jessica Antipenko, Natalie Presedo, Stephen E Cunningham, Tanya H Pierre, Kirk M Habegger

JCI Insight· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Fat and High-Sucrose Diets Impair Time-of-Day Differences in Spatial Working Memory of Male Mice.
Jennifer A Davis, Jodi R Paul, Laura J McMeekin, Shelly R Nason, Jessica P Antipenko, Kirk M Habegger

Obesity (Silver Spring)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Small Molecule, UAB126, Reverses Diet-Induced Obesity and its Associated Metabolic Disorders.
Guang Ren, Teayoun Kim, Hae-Suk Kim, Martin E Young, Donald D Muccio, Kirk M Habegger

Diabetes· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In utero nutritional stress as a cause of obesity: Altered relationship between body fat, leptin levels and caloric intake in offspring into adulthood.
Rogerio Sertie, Minsung Kang, Jessica P Antipenko, Xiaobing Liu, Lidia Maianu, Kirk Habegger

Life Sci· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization.
Manoja K Brahma, Chae-Myeong Ha, Mark E Pepin, Sobuj Mia, Zhihuan Sun, Kirk M Habegger

J Am Heart Assoc· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-Receptor Signaling Reverses Hepatic Steatosis Independent of Leptin Receptor Expression.
Shelly R Nason, Teayoun Kim, Jessica P Antipenko, Brian Finan, Richard DiMarchi, Kirk M Habegger

Endocrinology· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue "The Biology and Pharmacology of Glucagon".
Timo D Müller, Kirk Habegger

Int J Mol Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis